封面
市场调查报告书
商品编码
1767663

病毒安全测试服务市场(按测试类型、应用程式、最终用户和地区)

Virus Safety Testing Services Market, By Testing Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3个工作天内

价格
简介目录

病毒安全检测服务市场规模预计在 2025 年达到 6.824 亿美元,预计到 2032 年将达到 19.875 亿美元,2025 年至 2032 年的复合年增长率为年复合成长率%。

分析范围 分析详细信息
基准年 2024 市场规模(2025年) 6.824亿美元
效能数据 2020-2024 预测期 2025-2032
预测期内的复合年增长率(2025-2032) 16.50% 预计金额(2032年) 19.875亿美元

近年来,由于对确保生物製药产品安全和品质的需求不断增长,全球病毒安全检测服务市场经历了显着增长。病毒安全检测是生物製药产品生产过程中至关重要的环节,因为它有助于识别和去除可能对病人安全构成威胁的病毒污染物。该市场涵盖一系列服务,例如病毒清除测试、病毒惰性测试以及病毒检测和鑑定。由于生物製药产品日益复杂,且为确保其安全而製定的监管要求日益严格,预计对专业病毒安全检测服务的需求将持续成长。

市场动态:

全球病毒安全检测服务市场受到多种因素驱动,包括慢性病盛行率的上升、对生物製药需求的不断增长、以及确保这些产品安全性和品质的严格监管要求。癌症、糖尿病和自体免疫疾病等慢性病盛行率的上升导致对生物製药的需求增加,推动了病毒安全检测服务市场的成长。此外,单株抗体和重组蛋白等生物製药药物的日益复杂化使得需要专门的检测服务来确保其安全性和有效性。然而,病毒安全检测服务成本高昂以及缺乏标准化的检测通讯协定是限制市场成长的一些因素。儘管有这些挑战,市场仍提供了巨大的成长机会,尤其是在亚太地区和拉丁美洲等对生物製药药物需求旺盛的新兴市场。

本报告的主要特点

  • 本报告对全球病毒安全检测服务市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和复合年增长率。
  • 它还强调了每个细分市场的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球病毒安全检测服务市场的主要企业是根据公司概况、产品系列、主要亮点、财务绩效和策略等参数列出的。
  • 透过本报告的见解,负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 《全球病毒安全检测服务市场》报告涉及该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球病毒安全检测服务市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态

4. 全球病毒安全检测服务市场按检测类型划分(以金额为准,2020-2032 年)

  • 病毒检测测试
  • 病毒清除测试
  • 外来病毒检测
  • 病毒灭活服务
  • 抗体产生测试
  • 逆转录病毒检测
  • 其他病毒安全性研究

5. 全球病毒安全测试服务市场按应用划分(以金额为准,2020-2032 年)

  • 疫苗
  • 抗体
  • 基因和细胞治疗
  • 血液製品安全
  • 组织和基于组织的产品
  • 再生医学
  • 其他用途

6. 全球病毒安全测试服务市场(按最终用户和以金额为准),2020 年至 2032 年

  • 製药公司
  • 生物製药公司
  • CRO(委外研发机构)
  • 学术研究所
  • 其他的

7. 全球病毒安全检测服务市场按地区划分(以金额为准,2020-2032 年)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第八章 竞争态势

  • Charles River Laboratories
  • Lonza Group
  • Merck KGaA
  • WuXi AppTec
  • SGS SA
  • IDEXX Laboratories
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Abbot Laboratories
  • Becton, Dickinson and Company
  • GenScript Biotech Corporation
  • Viropro Inc.
  • PPD Inc.
  • Catalent Inc.

第九章 分析师建议

  • “命运之轮”
  • 分析师观点
  • Coherent Opportunity Map (COM)

第十章参考文献与调查方法

  • 参考
  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI8065

Virus Safety Testing Services Market is estimated to be valued at USD 682.4 Mn in 2025 and is expected to reach USD 1,987.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 16.50% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 682.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 16.50% 2032 Value Projection: USD 1,987.5 Mn

The global virus safety testing services market has witnessed significant growth in recent years, driven by the increasing demand for ensuring the safety and quality of biopharmaceutical products. Virus safety testing is a critical aspect of the biopharmaceutical manufacturing process, as it helps to identify and eliminate potential viral contaminants that could pose a threat to patient safety. The market encompasses a range of services, including viral clearance studies, viral inactivation studies, and virus detection and identification. With the growing complexity of biopharmaceutical products and the stringent regulatory requirements for ensuring their safety, the demand for specialized virus safety testing services is expected to continue to rise in the coming years.

Market Dynamics:

The global virus safety testing services market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for biopharmaceutical products, and the stringent regulatory requirements for ensuring the safety and quality of these products. The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has led to an increased demand for biopharmaceutical products, which, in turn, has fueled the growth of the virus safety testing services market. In addition, the increasing complexity of biopharmaceutical products, such as monoclonal antibodies and recombinant proteins, has created a need for specialized testing services to ensure their safety and efficacy. However, the high cost of virus safety testing services and the lack of standardized protocols for testing are some of the factors that could restrain the growth of the market. Despite these challenges, the market offers significant opportunities for growth, particularly in emerging markets such as Asia Pacific and Latin America, where the demand for biopharmaceutical products is increasing rapidly.

Key Features of the Study:

  • This report provides in-depth analysis of the global virus safety testing services market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global virus safety testing services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Charles River Laboratories, Lonza Group, Merck KGaA, WuXi AppTec, SGS SA, IDEXX Laboratories, Thermo Fisher Scientific, Eurofins Scientific, Abbot Laboratories, Becton, Dickinson and Company, GenScript Biotech Corporation, Viropro Inc., PPD Inc., and Catalent Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global virus safety testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virus safety testing services market

Market Segmentation

  • Testing Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Viral Detection Testing
    • Viral Clearance Testing
    • Adventitious Virus Testing
    • Viral Inactivation Services
    • Antibody Production Tests
    • Retrovirus Tests
    • Other Virus Safety Tests
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Vaccines
    • Antibodies
    • Gene and Cell Therapy
    • Blood Product Safety
    • Tissue & Tissue-based Products
    • Regenerative Medicine
    • Other Applications
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Academic and Research Institutes
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Charles River Laboratories
    • Lonza Group
    • Merck KGaA
    • WuXi AppTec
    • SGS SA
    • IDEXX Laboratories
    • Thermo Fisher Scientific
    • Eurofins Scientific
    • Abbot Laboratories
    • Becton, Dickinson and Company
    • GenScript Biotech Corporation
    • Viropro Inc.
    • PPD Inc.
    • Catalent Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Virus Safety Testing Services Market, By Testing Type
    • Global Virus Safety Testing Services Market, By Application
    • Global Virus Safety Testing Services Market, By End User
    • Global Virus Safety Testing Services Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Merger and Acquisition Scenario
    • Industry Trends

4. Global Virus Safety Testing Services Market, By Testing Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Viral Detection Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Viral Clearance Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Adventitious Virus Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Viral Inactivation Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Antibody Production Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retrovirus Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Virus Safety Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Virus Safety Testing Services Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Gene and Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Blood Product Safety
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Tissue & Tissue-based Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Virus Safety Testing Services Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Virus Safety Testing Services Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WuXi AppTec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SGS SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eurofins Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbot Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript Biotech Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Viropro Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PPD Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Catalent Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us